tesamorelin / ipamorelin + Blend Tesamorelin/Ipamorelin 13/3MG - Nurapeptide

This work was supported by Project funded by China Postdoctoral Science Foundation (2022M713650)

This is a research blend of two distinct and mechanistically complementary growth hormone secretagogues, supplied together to enable dual-pathway GH axis research in a single formulation

For further optimization, the central gene fragment of PapRS#0, flanked by the two Bsa I restriction sites, was subjected to error-prone PCR using the GeneMorph II random mutagenesis kit (Agilent), adjusting a mutagenesis frequency of 4 nucleotide exchanges

Appropriately using of Ipamorelin is as a rule safe, but sometimes the unexpected side effects of Ipamorelin can be noted